Financial statements Nova - Pharm

Balance sheet of Nova - Pharm

Company age:
Age:
12 y. 1 m. 11 d.
Share capital:
Share capital:
50 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of NOVA - PHARM

Year
2018
2019
2020
2021
2022
Total assets 1 321 797,84 994 863,70 1 211 848,43 861 597,83 1 167 626,58
A. Fixed assets 121 929,99 91 269,38 106 519,11 121 078,96 107 679,63
B. Current assets 1 199 867,85 903 594,32 1 105 329,32 740 518,87 1 059 946,95
C. Share capital contributions (basic funds) - - - - -
D. Own shares (stocks) - - - - -
Total liabilities 1 321 797,84 994 863,70 1 211 848,43 861 597,83 1 167 626,58
A. Equity 47 861,75 61 290,57 177 050,71 -123 270,69 -176 279,68
B. Liabilities and provisions for liabilities 1 273 936,09 933 573,13 1 034 797,72 984 868,52 1 343 906,26
I. Long-term liabilities 0,00 0,00 0,00 300 481,50 370 000,00
II. Short-term liabilities 1 163 079,40 844 216,38 982 043,28 640 062,70 912 750,71
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.